Literature DB >> 27371778

All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic.

Khalid Al-Rubeaan1, Amira M Youssef2, Heba M Ibrahim2, Ahmad H Al-Sharqawi3, Hamid AlQumaidi4, Dhekra AlNaqeb4, Khaled H Aburisheh4.   

Abstract

AIM: Diabetes mellitus is associated with an increased risk of premature death mainly secondary to macrovascular and microvascular complications. Mortality data from the Eastern Mediterranean region known for its high diabetes prevalence are lacking. We aimed to assess all-cause mortality and its predictors using large cohort from the Saudi National Diabetes Registry (SNDR).
METHODS: The study population comprised of 40,827 individuals with type 1 and type 2 diabetes mellitus aged ⩾25years registered in SNDR between January 2007 and December 2013. All patients were followed until death, according to the date of death or reaching 100years of age or end of the study. Death was verified from the national civil affairs database. The general population during the study period was used as a reference for standardized mortality ratio (SMR) calculation.
RESULTS: With a total of 152,038 person-years of follow up, 2582 patients were deceased giving all-cause mortality rate of 16.98 per 1000 person-years and SMR (95% CI) of 1.93 (1.86-2.00). Mortality rates were higher among men and increased with age, while SMR attenuated with increasing age. The independent predictors for all-cause mortality were longer diabetes duration, presence of macrovascular complications, nephropathy, retinopathy, hypertension, male gender and older age, while morbid obesity and the presence of hyperlipidemia were associated with reduced risk.
CONCLUSIONS: The unexpectedly low mortality rate in this population would be associated with higher number of deaths as a result of the high prevalence of diabetes and its complications. Reducing the prevalence of diabetes and its complications would reduce the risk of mortality.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  All-cause mortality; Diabetes mellitus; Risk factors; SMR; SNDR

Mesh:

Year:  2016        PMID: 27371778     DOI: 10.1016/j.diabres.2016.06.012

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Selective COVID-19 Coinfections in Diabetic Patients with Concomitant Cardiovascular Comorbidities Are Associated with Increased Mortality.

Authors:  Kamaleldin B Said; Ahmed Alsolami; Fawwaz Alshammari; Fayez Saud Alreshidi; Anas Fathuldeen; Fawaz Alrashid; Abdelhafiz I Bashir; Sara Osman; Rana Aboras; Abdulrahman Alshammari; Turki Alshammari; Sultan F Alharbi
Journal:  Pathogens       Date:  2022-04-25

2.  All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia.

Authors:  Khalid Al-Rubeaan; Mohammad K Almashouq; Amira M Youssef; Hamid Al-Qumaidi; Mohammad Al Derwish; Samir Ouizi; Khalid Al-Shehri; Saba N Masoodi
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

3.  All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes.

Authors:  Lelia L F de Abreu; Kara L Holloway; Mohammadreza Mohebbi; Muhammad A Sajjad; Mark A Kotowicz; Julie A Pasco
Journal:  J Diabetes Res       Date:  2017-06-18       Impact factor: 4.011

4.  Phenotyping individuals with newly-diagnosed type 2 diabetes at risk for all-cause mortality: a single centre observational, prospective study.

Authors:  Edoardo Biancalana; Federico Parolini; Alessandro Mengozzi; Anna Solini
Journal:  Diabetol Metab Syndr       Date:  2020-05-25       Impact factor: 3.320

5.  Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.

Authors:  Jingjing He; Desheng Kong; Zhifen Yang; Ruiyun Guo; Asiamah Ernest Amponsah; Baofeng Feng; Xiaolin Zhang; Wei Zhang; Aijing Liu; Jun Ma; Timothy O'Brien; Huixian Cui
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.